文献速递关节外科运动医学

解剖型全肩关节置换术患者的患者报告结局与健康相关生活质量评分

Patient-Reported Outcome Measures and Health-Related Quality-of-Life Scores of Patients Undergoing Anatomic Total Shoulder Arthroplasty.
PubMed 文献 · J Bone Joint Surg Am · 2019-01-01

本研究纳入145例(145肩)因晚期盂肱骨关节炎接受解剖型全肩关节置换术的患者,其中93例完成1年随访。术后1年所有患者报告结局量表(PROMs)与健康相关生活质量(HRQoL)评分均显著改善(p < 0.001)。VAS QoL与EQ-5D的改善与除SST外所有PROMs的改善呈弱至中度显著相关,且效应量大;SF-6D变化仅呈中度效应且与任何PROMs变化无显著相关。作者认为PROMs与HRQoL评分不可互换,成本效果与价值分析应同时纳入肩部及上肢PROMs和HRQoL评分。

要点

  • 解剖型全肩关节置换术后1年,所有PROMs与HRQoL评分均显著改善(p < 0.001)。
  • VAS QoL与EQ-5D的改善与除SST外所有PROMs的改善呈弱至中度显著相关。
  • SF-6D变化仅呈中度效应且与任何PROMs变化无显著相关。

核心结论

  • PROMs与HRQoL评分不可互换,肩关节置换术的成本效果与价值研究应同时纳入肩部及上肢PROMs和HRQoL评分。
  • 本研究提供了针对晚期盂肱骨关节炎解剖型全肩关节置换术的HRQoL评分数据,可用于未来成本效果与价值分析研究。

研究设计与样本

  • 研究分析了145例(145肩)因盂肱骨关节炎接受解剖型全肩关节置换术的患者,其中93例有1年随访数据。
  • 术前及术后功能结局采用DASH评分、ASES评分、SST及肩部疼痛与功能VAS评估;健康效用采用EQ-5D、SF-6D及VAS QoL评估。
  • HRQoL评分效度通过PROMs与HRQoL评分之间的相关性确定;反应性通过效应量和标准化反应均数衡量。
  • 证据等级为治疗性IV级。

主要发现

  • 术后1年所有PROMs和HRQoL评分均显著改善(p < 0.001)。
  • VAS QoL与EQ-5D的变化与除SST外所有PROMs的变化呈弱至中度显著相关,显示可接受的效度。
  • VAS QoL的效应量为1.833、标准化反应均数为1.603;EQ-5D的效应量为1.163、标准化反应均数为1.228,均显示反应性。
  • 所有PROMs的效应量均大于HRQoL评分的效应量。
  • SF-6D的变化仅呈中度效应量和标准化反应均数,且与任何PROMs的变化均无显著相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Health-related quality-of-life (HRQoL) scores are required for cost-effectiveness and health-care value analysis. We evaluated HRQoL scores and patient-reported outcome measures (PROMs) in patients with advanced glenohumeral osteoarthritis treated with anatomic total shoulder arthroplasty to establish values of HRQoL scores that can be used for cost-effectiveness and value analysis and to assess relationships between HRQoL scores and shoulder and upper-extremity PROMs. METHODS: We analyzed 145 patients (145 shoulders) with glenohumeral osteoarthritis treated with anatomic total shoulder arthroplasty; 93 patients had 1-year follow-up. Preoperative and postoperative functional outcomes were assessed with the Disabilities of the Arm, Shoulder and Hand (DASH) score, the American Shoulder and Elbow Surgeons (ASES) score, the Simple Shoulder Test (SST), and a visual analog scale (VAS) for shoulder pain and function. Health utility was assessed with the EuroQol-5 Dimensions (EQ-5D), Short Form-6 Dimensions (SF-6D), and VAS Quality of Life (VAS QoL). HRQoL score validity was determined through correlations between the PROMs and HRQoL scores. The responsiveness of HRQoL scores was measured through the effect size and the standardized response mean. RESULTS: There were significant improvements in all PROMs and HRQoL scores (p < 0.001) at 1 year after the surgical procedure. The changes in VAS QoL and EQ-5D were significantly correlated (weak to moderate) with the changes in all PROMs except the SST, demonstrating comparably acceptable validity. The VAS QoL had a large effect size (1.833) and standardized response mean (1.603), and the EQ-5D also had a large effect size (1.163) and standardized response mean (1.228), demonstrating responsiveness. The effect sizes of all PROMs were larger than those of the HRQoL scores. The change in SF-6D had only a moderate effect size and standardized response mean and was not significantly correlated with the change in any of the PROMs. CONCLUSIONS: PROMs and HRQoL scores are not interchangeable, and studies of the cost-effectiveness and value of shoulder arthroplasty should incorporate both shoulder and upper-extremity PROMs and HRQoL scores. The findings of this study provide data on HRQoL scores that are specific to the treatment of advanced glenohumeral osteoarthritis with anatomic total shoulder replacement and can be used for future cost-effectiveness and value analysis studies. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Jain SS, DeFroda SF, Paxton ES, et al. Patient-Reported Outcome Measures and Health-Related Quality-of-Life Scores of Patients Undergoing Anatomic Total Shoulder Arthroplasty. J Bone Joint Surg Am. 2019. PMID: 31483403. doi:10.2106/JBJS.19.00017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。